522 related articles for article (PubMed ID: 16083536)
1. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
Kemper F; Gebhardt U; Meng T; Murray C
Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
[TBL] [Abstract][Full Text] [Related]
2. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
Waddell DD; Cefalu CA; Bricker DC
Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
[TBL] [Abstract][Full Text] [Related]
3. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review.
Waddell DD; Bricker DC
J Surg Orthop Adv; 2006; 15(1):53-9. PubMed ID: 16603113
[TBL] [Abstract][Full Text] [Related]
4. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
[TBL] [Abstract][Full Text] [Related]
5. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada.
Lussier A; Cividino AA; McFarlane CA; Olszynski WP; Potashner WJ; De Médicis R
J Rheumatol; 1996 Sep; 23(9):1579-85. PubMed ID: 8877928
[TBL] [Abstract][Full Text] [Related]
6. Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study.
Goorman SD; Watanabe TK; Miller EH; Perry C
Arch Phys Med Rehabil; 2000 Apr; 81(4):479-83. PubMed ID: 10768539
[TBL] [Abstract][Full Text] [Related]
7. Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis.
Theiler R; Brühlmann P
Curr Med Res Opin; 2005 Nov; 21(11):1727-33. PubMed ID: 16307692
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
[TBL] [Abstract][Full Text] [Related]
9. Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK).
Clarke S; Lock V; Duddy J; Sharif M; Newman JH; Kirwan JR
Knee; 2005 Jan; 12(1):57-62. PubMed ID: 15664879
[TBL] [Abstract][Full Text] [Related]
10. Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections?
Pullman-Mooar S; Mooar P; Sieck M; Clayburne G; Schumacher HR
J Rheumatol; 2002 Dec; 29(12):2611-4. PubMed ID: 12465161
[TBL] [Abstract][Full Text] [Related]
11. Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee.
Hammesfahr JF; Knopf AB; Stitik T
Am J Orthop (Belle Mead NJ); 2003 Jun; 32(6):277-83. PubMed ID: 12834190
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
[TBL] [Abstract][Full Text] [Related]
13. Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee.
Kolarz G; Kotz R; Hochmayer I
Semin Arthritis Rheum; 2003 Apr; 32(5):310-9. PubMed ID: 12701041
[TBL] [Abstract][Full Text] [Related]
14. A prospective multi-centre, open study of the safety and efficacy of hylan G-F 20 (Synvisc) in patients with symptomatic ankle (talo-crural) osteoarthritis.
Witteveen AG; Giannini S; Guido G; Jerosch J; Lohrer H; Vannini F; Donati L; Schulz A; Scholl J; Sierevelt IN; van Dijk CN
Foot Ankle Surg; 2008; 14(3):145-52. PubMed ID: 19083633
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
[TBL] [Abstract][Full Text] [Related]
16. The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis.
Zietz PM; Selesnick H
Arthroscopy; 2008 Apr; 24(4):416-22. PubMed ID: 18375273
[TBL] [Abstract][Full Text] [Related]
17. The use of intra-articular hylan G-F 20 in the treatment of symptomatic osteoarthritis of the shoulder: a preliminary study.
Silverstein E; Leger R; Shea KP
Am J Sports Med; 2007 Jun; 35(6):979-85. PubMed ID: 17395958
[TBL] [Abstract][Full Text] [Related]
18. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.
Waddell D; Rein A; Panarites C; Coleman PM; Weiss C
Am J Manag Care; 2001 Oct; 7(10):981-91. PubMed ID: 11669362
[TBL] [Abstract][Full Text] [Related]
19. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee.
Caborn D; Rush J; Lanzer W; Parenti D; Murray C;
J Rheumatol; 2004 Feb; 31(2):333-43. PubMed ID: 14760806
[TBL] [Abstract][Full Text] [Related]
20. The effect of viscosupplementation on neuromuscular control of the knee in patients with osteoarthritis.
Diracoglu D; Vural M; Baskent A; Dikici F; Aksoy C
J Back Musculoskelet Rehabil; 2009; 22(1):1-9. PubMed ID: 20023357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
